
Global Clinical Research, Quality and Regulatory Consulting Services
Established CRO with Clinical, Quality and Regulatory consulting services and solutions for In Vitro Diagnostics, Medical Devices, and Biopharmaceuticals.
OUR SPECIALTIES
Landrich Group specializes in advancing In Vitro Diagnostics, Medical Devices, Companion Diagnostics, and Biopharma through Clinical research, Quality, and Regulatory consulting services.
In Vitro
Diagnostics
Companion
Diagnostics
Precision Medicine
Medical Devices
Biopharma
OUR SERVICES
















Kalavati Bhashyam
Former Vice President of Products at Harmonic Bionics, Inc.
"Tina came very highly recommended to us at a time when we were looking for someone to help us navigate the regulatory requirements on investigational devices, support us in the preparation of a GCP compliant documentation system as a Sponsor and Investigational Site and submit our own clinical study protocol with an independent IRB. No one in the company had prior experience in navigating any of this!
Tina was fantastic – she was very practical in establishing the regulatory requirements that our company was obligated to. She was also very flexible in helping us adapt a process for the preparation and review of our documentation while staying within our budget. She has tremendous attention to detail, a very high work ethic, and incredible dedication to assisting you achieve your goals. She also has a very talented staff augmenting her expertise to provide a well-rounded team for your clinical project."
FAQs
Landrich Group is a specialized consulting firm based in Alameda, California, with a strong global presence and a proven track record of success across international markets. We offer expert clinical, regulatory, and quality services to clients in the medical device, in vitro diagnostics (IVD), and pharmaceutical industries. Our team supports the full product development life cycle—from early design and development through clinical trials, regulatory submissions, global clearances (including FDA, EU, and other international authorities), approvals, and post-market activities.
Landrich Group provides a wide range of expert consulting services to support medical device, IVD, and pharmaceutical companies throughout the entire product lifecycle. With a strong global presence, we assist clients navigating complex regulatory and clinical environments in the U.S., EU, and other international markets. Our core capabilities include:
Clinical Services (CRO) – Full-service clinical trial management and monitoring.
Quality Assurance – Offering QMS gap assessments, QMS implementation, FDA, EU and other region inspection readiness support.
Regulatory Affairs – Strategic regulatory guidance including FDA, EU MDR/IVDR, and international submissions etc., pre-sub meetings, submissions, and post-market support.
Quality Management Systems – Design, implementation, and auditing of QMS.
Data Management – Clinical data handling, validation, and reporting across multiple regulatory jurisdictions.
U.S. Agent Services – Acting as U.S. Agent for foreign (ex-US) manufacturers to coordinate communications with the FDA to ensure regulatory compliance. For non-U.S. companies, the FDA requires the designation of a U.S. Agent—and we're here to fulfill that role with clarity and confidence.
GCP/GMP Training – Custom training programs on Good Clinical/Manufacturing Practices.
SOP Development – Develop and optimization of Standard Operating Procedures to meet global compliance requirements.
R&D Support – Technical, quality and regulatory assistance for analytical and clinical performance evaluation studies during product development.
Biostatistics – Statistical planning, analysis, and reporting for clinical studies.
We tailor our services to meet your specific needs, from early-stage development to post-market support, across U.S. and international markets.
We serve a broad range of companies, from startups to established global multinational corporations in the medical device, diagnostics, and pharmaceutical industries. Our clients often seek support during critical milestones such as regulatory submissions, clinical trials design, planning and execution, or QMS inspections.
Landrich Group stands out for its deep industry expertise, highly personalized approach, and proven track record of successful product development and regulatory clearance—both in the U.S. and globally. Our team brings decades of hands-on experience and works as a true extension of your internal team, customizing solutions to fit your goals across global markets and regulatory landscapes.
Since 2016, we have maintained a 100% success rate across 20 programs and 19 regulatory submissions, including 510(k)s, Emergency Use Authorizations (EUAs), and clinical evaluations in infectious diseases, oncology, and diagnostics. Our results include:
0% Warning Letters
0% FDA 483 findings
100% success in areas such as Usability, Reproducibility, Reference Range, and QMS inspections
These metrics reflect our unwavering commitment to quality, compliance, and client success.
Yes, Landrich Group provides full support for FDA pre-submission meetings, IDEs, 510(k)s, De Novo 510(k)s, PMAs, EU IVDR and MDR Technical File Dossiers. We also help interpret feedback from the FDA and other National Competent Authorities to and adjust your clinical or regulatory strategy accordingly.
OUR INDUSTRY EXPERIENCE AND PROGRAMS SUPPORTED BY LANDRICH GROUP


















LANDRICH GROUP GLOBAL EXPERIENCE
Sponsor
Regions
Site
The Landrich Group has conducted trials in 6 / 7 continents as of 2025.